Pictet holds first close for healthcare fund-of-funds
Pictet Alternative Advisors (PAA) has held a first close for its healthcare fund-of-funds towards its target of USD 400m, the GP told Unquote.
Pictet Alternative Advisors (PAA) has held a first close for its healthcare fund-of-funds towards its target of USD 400m, the GP told Unquote.
Finnish private equity firm Vaaka Partners has bought Medbase, a provider of databases to healthcare professionals that help to reduce adverse reactions to drugs.
Cenexi, a contract development and manufacturing organization (CDMO) specialised in high sterile products, is the next healthcare deal to hit the auction block in France, according to seven sources familiar with the matter.
Gilde Healthcare has bought cannular manufacturer Europin from its private equity funds, to merge with portfolio company Acti-Med.
Global private equity firm Warburg Pincus and Abu Dhabi sovereign wealth fund Mubadala Investment Company have bought Informa's Pharma Intelligence division for GBP 1.9bn, an entry multiple of 20-25x.
US private equity house Genstar Capital is reportedly hoping to reach a $5bn price tag for pharmaceuticals and regulatory consulting business Advarra through a potential sale. The post Genstar Capital said to eye over $5bn
Global buyout major Warburg Pincus, has partnered with Abu Dhabi-based investment firm Mubadala to acquire Pharma Intelligence from London-listed Informa. The post Warburg Pincus partners with Mubadala to acquire Pharma Intelligence, eyeing the $22bn pharma
Lauxera Capital Partners has closed its first fund, Lauxera Growth I, on EUR 260m, exceeding its hard-cap of EUR 200m.
Lauxera Capital Partners has raised one of Europe's biggest healthtech-focused fundraises with its debut vehicle by soaring past its target to reach a €260m final close. The post Lauxera smashes target for debut fund looking
Canadian healthtech investor iGan Partners has teamed with Dubai-based entrepreneur Faisal Belhoul to launch a $250m fund targeting medtech deals across the MENA region. The post Canada’s iGan Partners to tap booming MENA medtech sector
Spanish private equity firm Abac Capital has sold all of the share capital of dietary company PronoKal to Nestlé Health Science.
